POZEN INC /NC FILES (8-K) Disclosing Other Events

Edgar Glimpses |

Item 8.01. Other Events

On July 1, 2014, POZEN Inc., a Delaware corporation (POZEN), issued a press release to report the resubmission of its New Drug Application for PA32540 and PA8140 to the U.S. Food and Drug Administration (FDA).

--------------------------------------------------------------------------------

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
TLCO Teleconnect Inc 0.05 0.00 0.00 0

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
XOM

     

World Economic Forum at Davos 2019 - Frank Ricotta CEO BurstIQ

Matt Bird sits down with Frank Ricotta, CEO BurstIQ, at the World Economic Forum at Davos 2019